A father left paralysed by AstraZeneca’s Covid vaccine killed himself after being denied compensation. John Cross, who ...

Astrazeneca (AZN) ended the recent trading session at $174.93, demonstrating a -1.66% change from the preceding day's closing price. This change lagged the S&P 500's 1.09% gain on the day. On the ...

AstraZeneca AZN announced that the FDA has accepted a regulatory filing seeking to expand the use of its blockbuster rare ...

AstraZeneca’s SOUNDTRACK-F1 study aims to improve on related risks seen with chemotherapy-including treatments in follicular ...

If the Phase III trials of the oral GLP-1RA are successful, AstraZeneca is set to join a fast-growing market.

ZERO Prostate Cancer, the nation's leading prostate cancer organization dedicated to advocacy, awareness, education, and ...

A new GLP-1 oral medication from AstraZeneca, known as elecoglipron, lowered blood sugar levels and led to 10.5% weight loss ...

AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout ...

View AstraZeneca PLC AZN stock quote prices, financial information, real-time forecasts, and company news from CNN.

The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or ...

AstraZeneca said on Monday that patients lost 10.5% of their body weight after 26 weeks in a mid-stage trial of ​its ...

AstraZeneca’s Truqap (capivasertib) gained FDA approval, combined with abiraterone and prednisone, for treatment of certain ...